ReutersFDA approves Glaxo, Theravance's Breo Ellipta asthma drugReuters(Reuters) - The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said. The FDA declined to approve Breo for younger ...FDA Approves BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma in ...CNNMoneyGlaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloombergFDA approves Glaxo's inhaler drug Breo Ellipta for new use in treating adults ...Minneapolis Star TribuneHCPLiveall 22 news articles »
FDA approves Glaxo, Theravance's Breo Ellipta asthma drug
Rating: 4.5
Diposkan Oleh: Unknown
